Infectious Diseases

Projects

Projects per year 1998 2011 2022

• 3 Active
• 32 Finished

Projects per year

Search results

• Active

  Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence

  Badley, A. D.

  National Institute of Allergy and Infectious Diseases

  8/2/21 → 7/31/22

  Project: Research project

  • T-Lymphocytes 100%
  • HIV 98%
  • Apoptosis 53%
  • TNF-Related Apoptosis-Inducing Ligand Receptors 52%
  • T-Cell Antigen Receptor 37%

• Mechanisms of Ebola virus-mediated inflammatory activation linked to pathogenesis

  Barry, M. A. & Ebihara, H.

  National Institute of Allergy and Infectious Diseases

  8/15/19 → 7/31/22

  Project: Research project

  • Ebolavirus 100%
  • Ebola virus nucleoprotein VP40 59%
  • Systemic Inflammatory Response Syndrome 25%
  • Viruses 20%
  • Reston 18%

• Oncolytic Single-Cycle Replicating Immunotherapies for Kidney Cancer

  Barry, M. A.

  Congressionally Directed Medical Research Programs

  1/1/18 → …

  Project: Research project

  • kidney neoplasms 100%
  • immunotherapy 48%
  • therapeutics 45%
  • immune system 41%
  • neoplasm cells 39%
• Finished

  Oncolytic Single-Cycle Replicating Immunotherapies for Kidney Cancer

  Barry, M. A.

  U.S. Army

  9/30/19 → 9/29/21

  Project: Research project

  • kidney neoplasms 100%
  • immunotherapy 48%
  • therapeutics 45%
  • immune system 41%
  • neoplasm cells 39%

• ONCOLYTIC SINGLE-CYCLE REPLICATING IMMUNOTHERAPIES FOR KIDNEY CANCER

  Barry, M. A.

  Congressionally Directed Medical Research Programs

  9/30/19 → 9/29/21

  Project: Research project

  • Kidney Neoplasms 100%
  • Adenoviridae 81%
  • Oncolytic Viruses 72%
  • Immunotherapy 59%
  • Seroepidemiologic Studies 34%

• Stories for Change (S4C): Digital Storytelling for Diabetes Self-Management among Hispanic Adults

  Sia, I. G. & Wieland, M. L.

  National Institute of Diabetes and Digestive and Kidney Diseases

  6/19/18 → 5/31/21

  Project: Research project

  • Community-Based Participatory Research 100%
  • Self-Management 99%
  • Hispanic Americans 92%
  • Type 2 Diabetes Mellitus 68%
  • Medication Adherence 50%

• Vaccine Synergy through Synchronous Delivery

  Barry, M. A. & Sastry, J.

  National Institute of Allergy and Infectious Diseases

  2/5/18 → 1/31/20

  Project: Research project

  • vaccines 100%
  • immunization 68%
  • mucosal immunity 58%
  • vaccination 50%
  • animals 35%

• Mucosal Single-Cycle Vaccines against Zika Virus

  Barry, M. A.

  National Institute of Allergy and Infectious Diseases

  9/5/17 → 8/31/19

  Project: Research project

  • Zika Virus 100%
  • Vaccines 70%
  • Adenoviridae Infections 13%
  • Antigens 13%
  • Genes 12%

• Engineering an HIV-resistant immune system for HIV cure

  Fadel, H.

  National Institute of Allergy and Infectious Diseases

  1/1/16 → 12/31/21

  Project: Research project

  • HIV-1 100%
  • Immune System 77%
  • HIV 74%
  • Hematopoietic Stem Cells 30%
  • Genetic Therapy 21%

• Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.

  Badley, A. D.

  National Institute of Allergy and Infectious Diseases

  6/15/15 → 5/31/21

  Project: Research project

  • HIV 100%
  • Apoptosis 76%
  • TNF-Related Apoptosis-Inducing Ligand Receptors 33%
  • HIV Infections 28%
  • Natural Killer Cells 22%

• Prime shock and kill for HIV erradication

  Badley, A. D.

  National Institute of Allergy and Infectious Diseases

  2/15/14 → 4/30/22

  Project: Research project

  • Shock 100%
  • HIV 86%
  • T-Lymphocytes 45%
  • Human Immunodeficiency Virus Proteins 24%
  • Apoptosis Regulatory Proteins 21%

• Enhancing control of HIV by inhibiting TRAILshort

  Badley, A. D.

  National Institute of Allergy and Infectious Diseases

  7/2/13 → 6/1/15

  Project: Research project

  • HIV 100%
  • Natural Killer Cells 39%
  • HIV Infections 38%
  • Berlin 26%
  • Preliminary Data 23%

• TB CENTER GRANT

  Temesgen, Z.

  National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

  1/1/13 → 12/31/17

  Project: Research project

• TB CENTER GRANT

  Temesgen, Z.

  National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

  1/1/13 → 12/31/17

  Project: Research project

• TB CENTER GRANT

  Temesgen, Z.

  National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

  1/1/13 → 12/31/17

  Project: Research project

• Immunoevasive Mucosal Vaccines Against HIV-1

  Barry, M. A.

  National Institute of Allergy and Infectious Diseases

  6/15/12 → 5/31/18

  Project: Research project

  • HIV-1 100%
  • Vaccines 98%
  • Immunization 77%
  • Serogroup 50%
  • Macaca 40%

• Regulation of HIV-Mediated CD4 T Cell Apoptosis

  Badley, A. D.

  National Institute of Allergy and Infectious Diseases

  5/15/12 → 12/31/13

  Project: Research project

  • T-Lymphocytes 100%
  • HIV 92%
  • Apoptosis 82%
  • KRH 1636 45%
  • Human Immunodeficiency Virus tat Gene Products 30%

• Healthy Immigrant Families: Working Together To Move More and To Eat Well

  Nigon, J. A., Sia, I. G. & Wieland, M. L.

  National Heart, Lung, and Blood Institute

  12/15/11 → 11/30/18

  Project: Research project

  • immigrant 100%
  • nutrition 74%
  • refugee 72%
  • blood pressure 26%
  • adolescent 24%

• STRENGTHENING HUMAN RESOURCES FOR HEALTH THROUGH CONTINUING EDUCATION OF HEALTH W

  Temesgen, Z.

  Center for Global Health, Centers for Disease Control and Prevention

  9/30/11 → 9/29/16

  Project: Research project

• GH11-1167, STRENGTHENING HUMAN RESOURCES FOR HEALTH THROUGH CONTINUING EDUCATION

  Temesgen, Z.

  Center for Global Health, Centers for Disease Control and Prevention

  9/30/11 → 9/29/16

  Project: Research project

• GH11-1167, STRENGTHENING HUMAN RESOURCES FOR HEALTH THROUGH CONTINUING EDUCATION

  Temesgen, Z.

  Center for Global Health, Centers for Disease Control and Prevention

  9/30/11 → 9/29/16

  Project: Research project

• GH11-1167, STRENGTHENING HUMAN RESOURCES FOR HEALTH THROUGH CONTINUING EDUCATION

  Temesgen, Z.

  Center for Global Health, Centers for Disease Control and Prevention

  9/30/11 → 9/29/16

  Project: Research project

• GH11-1167, STRENGTHENING HUMAN RESOURCES FOR HEALTH THROUGH CONTINUING EDUCATION

  Temesgen, Z.

  Center for Global Health, Centers for Disease Control and Prevention

  9/30/11 → 9/29/16

  Project: Research project

• STRENGTHENING HUMAN RESOURCES FOR HEALTH THROUGH CONTINUING EDUCATION OF HEALTH W

  Temesgen, Z.

  Center for Global Health, Centers for Disease Control and Prevention

  9/30/11 → 9/29/16

  Project: Research project

• GH11-1167, STRENGTHENING HUMAN RESOURCES FOR HEALTH THROUGH CONTINUING EDUCATION

  Temesgen, Z.

  Center for Global Health, Centers for Disease Control and Prevention

  9/30/11 → 9/29/16

  Project: Research project

• GH11-1167, STRENGTHENING HUMAN RESOURCES FOR HEALTH THROUGH CONTINUING EDUCATION

  Temesgen, Z.

  Center for Global Health, Centers for Disease Control and Prevention

  9/30/11 → 9/29/16

  Project: Research project

• Improving the Pharmacology of Oncolytic Adenovirus

  Barry, M. A.

  National Cancer Institute

  3/1/10 → 12/31/15

  Project: Research project

  • Adenoviridae 100%
  • Pharmacology 67%
  • Oncolytic Viruses 50%
  • Neoplasms 37%
  • Viruses 26%

• Mucosal Helper-dependent Adenovirus Vaccines Against HIV

  Barry, M. A.

  National Institute of Allergy and Infectious Diseases

  9/12/09 → 2/28/11

  Project: Research project

  • Adenovirus Vaccines 100%
  • Vaccines 80%
  • Immunization 70%
  • Serogroup 45%
  • HIV 42%

• Building Partnerships to Promote Health in Low Literacy Populations

  Sia, I. G.

  National Institute of Allergy and Infectious Diseases

  9/30/08 → 8/31/11

  Project: Research project

  • literacy 100%
  • contagious disease 87%
  • health 69%
  • scientific community 54%
  • evaluation 40%

• Mucosal Reovirus-Adenovirus Vaccines Against HIV-1

  Barry, M. A.

  National Institute of Allergy and Infectious Diseases

  12/15/07 → 5/30/12

  Project: Research project

  • Adenovirus Vaccines 100%
  • HIV-1 57%
  • Vaccines 55%
  • Mucosal Immunity 39%
  • Immunization 26%

• Mucosal Helper-dependent Adenovirus Vaccines Against HIV-1

  Barry, M. A.

  National Institute of Allergy and Infectious Diseases

  4/1/06 → 9/11/09

  Project: Research project

  • Adenovirus Vaccines 100%
  • HIV-1 58%
  • Vaccines 55%
  • Neutralizing Antibodies 48%
  • Serogroup 44%

• Procaspase 8 Activation by HIV Protease

  Badley, A. D.

  National Institute of Allergy and Infectious Diseases

  5/1/04 → 4/30/09

  Project: Research project

  • HIV Protease 100%
  • Caspase 8 61%
  • Apoptosis 13%
  • Human Immunodeficiency Virus Proteins 10%
  • Mutation 8%

• Significance of HIV Protease Cleavage of Procaspase 8

  Badley, A. D.

  National Institute of Allergy and Infectious Diseases

  9/1/03 → 8/31/04

  Project: Research project

  • HIV Protease 100%
  • Caspase 8 49%
  • T-Lymphocytes 14%
  • Apoptosis 14%
  • Infections 11%

• Cell Targeting Ligands and Vectors for CLL

  Barry, M. A.

  National Cancer Institute

  8/1/02 → 7/31/07

  Project: Research project

  • B-Cell Chronic Lymphocytic Leukemia 100%
  • Ligands 58%
  • Genetic Therapy 28%
  • Genes 10%
  • Heterografts 6%

• Regulation of HIV-Mediated CD4 T Cell Apoptosis

  Paya, C. & Badley, A. D.

  National Institute of Allergy and Infectious Diseases

  4/1/98 → 5/14/12

  Project: Research project

  • Caspases 100%
  • HIV 96%
  • T-Lymphocytes 86%
  • Apoptosis 82%
  • Parenchymal Tissue 72%